These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1529986)

  • 1. Multidisciplinary drug-use evaluation for stress ulcer prophylaxis.
    Hatton J
    Am J Hosp Pharm; 1992 Jun; 49(6):1440-4. PubMed ID: 1529986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
    Zeigler AJ; McAllen KJ; Slot MG; Barletta JF
    Ann Pharmacother; 2008 Jul; 42(7):940-6. PubMed ID: 18577762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overuse of stress ulcer prophylaxis in the critical care setting and beyond.
    Farrell CP; Mercogliano G; Kuntz CL
    J Crit Care; 2010 Jun; 25(2):214-20. PubMed ID: 19683892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
    Sesler JM
    AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
    Hatch JB; Schulz L; Fish JT
    Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
    Heidelbaugh JJ; Inadomi JM
    Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic benefit of practice guidelines for stress ulcer prophylaxis.
    Mostafa G; Sing RF; Matthews BD; Pratt BL; Norton HJ; Heniford BT
    Am Surg; 2002 Feb; 68(2):146-50. PubMed ID: 11842960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuity through best practice: design and implementation of a nurse-led community leg-ulcer service.
    Lorimer K
    Can J Nurs Res; 2004 Jun; 36(2):105-12. PubMed ID: 15369168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.
    Frandah W; Colmer-Hamood J; Nugent K; Raj R
    J Intensive Care Med; 2014; 29(2):96-103. PubMed ID: 22786980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy-coordinated process for evaluating physician drug prescribing.
    Peterson CD; Goldberg DE
    Am J Hosp Pharm; 1989 Sep; 46(9):1787-91. PubMed ID: 2508469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices.
    Byrnes MC; Schuerer DJ; Schallom ME; Sona CS; Mazuski JE; Taylor BE; McKenzie W; Thomas JM; Emerson JS; Nemeth JL; Bailey RA; Boyle WA; Buchman TG; Coopersmith CM
    Crit Care Med; 2009 Oct; 37(10):2775-81. PubMed ID: 19581803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
    Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
    Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward.
    Khalili H; Dashti-Khavidaki S; Hossein Talasaz AH; Tabeefar H; Hendoiee N
    J Manag Care Pharm; 2010 Mar; 16(2):114-21. PubMed ID: 20178396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality and outcome: pharmacy's professional imperative.
    Enright SM; Flagstad MS
    Am J Hosp Pharm; 1991 Sep; 48(9):1908-11. PubMed ID: 1928131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.